UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056135
Receipt number R000064122
Scientific Title Observational Study about Factors of Accidents in Marathons
Date of disclosure of the study information 2024/11/25
Last modified on 2024/11/12 18:45:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational Study about Factors of Accidents in Marathons

Acronym

Observational Study about Factors of Accidents in Marathons

Scientific Title

Observational Study about Factors of Accidents in Marathons

Scientific Title:Acronym

Observational Study about Factors of Accidents in Marathons

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the factors that contribute to the occurrence of accidents in marathons

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Whether or not an accident occurred during the marathon run

Key secondary outcomes

Data acquired from wearable device
First-aid record
Questionnaire(fatigue, etc.)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Males and females aged between 18 and 75

Key exclusion criteria

Subjects who judged as unsuitable for the study by the investigator

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name Kei
Middle name
Last name Yui

Organization

EZAKI GLICO Co., Ltd.

Division name

Wellness Innovation Business Division

Zip code

555-8502

Address

4-6-5, Utajima, Nishiyodogawa-ku, Osaka, 555-8502, Japan

TEL

+81-6-6477-8793

Email

kei.yui@glico.com


Public contact

Name of contact person

1st name Soshi
Middle name
Last name Tokiwa

Organization

EZAKI GLICO Co., Ltd.

Division name

Wellness Innovation Business Division

Zip code

555-8502

Address

4-6-5, Utajima, Nishiyodogawa-ku, Osaka, 555-8502, Japan

TEL

+81-6-6477-8442

Homepage URL


Email

soshi.tokiwa@glico.com


Sponsor or person

Institute

EZAKI GLICO Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

EZAKI GLICO Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Runner's Wellness, Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Institutional Review Board of Glico Group

Address

4-6-5 Utajima, Nishiyodogawa-ku, Osaka 555-8502, Japan

Tel

+81-6-6477-8352

Email

kazunori.nishi@glico.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 15 Day

Date of IRB


Anticipated trial start date

2024 Year 11 Month 25 Day

Last follow-up date

2024 Year 12 Month 08 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The following hypothetical hypothesis will be used to examine the influencing factors:
The frequency of marathon accidents and running records may be related to beverage intake and daily life.


Management information

Registered date

2024 Year 11 Month 12 Day

Last modified on

2024 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064122